Anvest Score
67/100
Valuation
59/100
Quality
100/100
Growth
60/100
Health
—
OmittedMomentum
32/100
- Valuation59
- Quality100
- Growth60
- Health—
- Momentum32
Loading company profile…
Fundamentals
P/E Ratio (TTM)
7.8
Sector median P/E
32.29
P/B Ratio
—
Sector median P/B
4.4
EPS (TTM)
₹20.11
ROE
148.24%
ROCE
163.14%
Profit Margin
17.12%
SPECIALITY MEDICINES LIMITED FAQs
3 topicsExpandCollapse
SPECIALITY MEDICINES LIMITED FAQs
3 topicsWhat does the SPECIALITY MEDICINES LIMITED (SPML) stock page cover?
SPECIALITY MEDICINES LIMITED on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for SPML?
SPECIALITY MEDICINES LIMITED is currently shown with a delayed price near ₹156.9, P/E 7.8, and ROE 148.24%.
Does the SPML page provide investment advice?
No. The SPML page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring